Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors.
Br J Cancer. 2005 May 23;92(10):1922-6. doi: 10.1038/sj.bjc.6602557.
Br J Cancer. 2005.
PMID: 15841079
Free PMC article.